First COVID-19 case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.
COVID-19
Diagnosis
Phylogenetic analyses
SARS-CoV-2
Zambia
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
14
09
2020
revised:
29
09
2020
accepted:
30
09
2020
pubmed:
10
10
2020
medline:
15
1
2021
entrez:
9
10
2020
Statut:
ppublish
Résumé
Since its first discovery in December 2019 in Wuhan, China, COVID-19, caused by the novel coronavirus SARS-CoV-2, has spread rapidly worldwide. While African countries were relatively spared initially, the initial low incidence of COVID-19 cases was not sustained for long due to continuing travel links between China, Europe and Africa. In preparation, Zambia had applied a multisectoral national epidemic disease surveillance and response system resulting in the identification of the first case within 48 h of the individual entering the country by air travel from a trip to France. Contact tracing showed that SARS-CoV-2 infection was contained within the patient's household, with no further spread to attending health care workers or community members. Phylogenomic analysis of the patient's SARS-CoV-2 strain showed that it belonged to lineage B.1.1., sharing the last common ancestor with SARS-CoV-2 strains recovered from South Africa. At the African continental level, our analysis showed that B.1 and B.1.1 lineages appear to be predominant in Africa. Whole genome sequence analysis should be part of all surveillance and case detection activities in order to monitor the origin and evolution of SARS-CoV-2 lineages across Africa.
Identifiants
pubmed: 33035675
pii: S1201-9712(20)32196-2
doi: 10.1016/j.ijid.2020.09.1480
pmc: PMC7537667
pii:
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
455-459Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Références
Emerg Infect Dis. 2009 Oct;15(10):1598-602
pubmed: 19861052
BMC Health Serv Res. 2020 Jan 13;20(1):35
pubmed: 31931793
JAMA. 2020 May 26;323(20):2089-2090
pubmed: 32320008
Bull World Health Organ. 2020 Jul 1;98(7):495-504
pubmed: 32742035
J Infect Dis. 2018 Nov 22;218(suppl_5):S312-S317
pubmed: 29889270
Int J Clin Pract. 2020 Aug;74(8):e13525
pubmed: 32374903
Emerg Infect Dis. 2019 Aug;25(8):1577-1580
pubmed: 31146800
Int J Infect Dis. 2020 Apr;93:233-236
pubmed: 32119980
J Infect Dis. 2012 Dec 15;206 Suppl 1:S173-7
pubmed: 23169966
J Infect Dis. 2015 Oct 1;212 Suppl 2:S101-8
pubmed: 25786916
Int Forum Allergy Rhinol. 2020 Jul;10(7):821-831
pubmed: 32329222
J Infect Dis. 2018 Oct 15;218(suppl_3):S181-S183
pubmed: 30215738
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813
pubmed: 32279441
J Gen Virol. 2011 Jun;92(Pt 6):1416-1427
pubmed: 21367986
Nucleic Acids Res. 2016 Jul 8;44(W1):W232-5
pubmed: 27084950
Emerg Infect Dis. 2020 Oct;26(10):2411-2415
pubmed: 32614767
Lancet. 2020 Mar 14;395(10227):871-877
pubmed: 32087820
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Brief Bioinform. 2019 Jul 19;20(4):1160-1166
pubmed: 28968734
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Mol Biol Evol. 2013 May;30(5):1188-95
pubmed: 23418397